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Clinical and Echocardiographic
Variables Associated With
LA Septal Pouch
The left atrial septal pouch (LASP) has been proposed as a
nidus for thrombogenesis with potential embolic complications,
including stroke, because of a low-ﬂow state within (1). A small
number of published studies suggest that much remains un-
known about this anatomical entity, including its prevalence,
features, and associations. Krishnan and Salazar (1) reported a
higher prevalence of LASP in younger populations, while
Tugcu et al. (2) showed a lack of association between the
prevalence of LASP and ischemic or cryptogenic stroke. The
objectives of our study were to deﬁne the demographic, clinical,
and echocardiographic correlates of LASP and to examine the
association of this entity with cryptogenic stroke from a larger
study sample.
Consecutive patients undergoing transesophageal echocar-
diography (TEE) for any indication at our institution from
January 2007 to December 2010 constituted the initial sample
(n ¼ 701) of this study. All patients underwent detailed eval-
uation of the atrial septum during TEE, per the protocol for our
echocardiography laboratory. Three investigators (S.A.W.,
J.H.P., and C.A.S.) reviewed patients’ transesophageal and
transthoracic echocardiograms to evaluate the presence and
features of LASP and to determine other echocardiographic
parameters (Table 1). Patients’ charts were reviewed by
3 investigators (S.A.W., B.P., and S.S.) to determine baseline
demographic and clinical characteristics. Ischemic stroke was
diagnosed by neurologists at our institution on the basis of
clinical (National Institutes of Health Stroke Scale) and imaging
(computed tomography or magnetic resonance imaging)
criteria. The diagnosis of stroke preceded TEE in all patients.
Cryptogenic stroke in our study was deﬁned as ischemic stroke
with absence of atrial septal defect or shunt, atrial ﬁbrillation,
>4 mm aortic arch plaque, and ﬂow-limiting carotid disease (as
determined by ultrasound or computed tomographic imaging).
All adult (age >18 years) patients undergoing TEE from
2007 to 2010 at our institution were included. Exclusion criteria
for our study were the presence of an atrial-level shunt
(patent foramen ovale or atrial septal defect) detected by
color ﬂow Doppler imaging and/or saline contrast injection with
or without Valsalva maneuver, post-ablation TEE (involving
transseptal puncture), transesophageal echocardiographic
studies with deﬁcient information regarding possible extrac-
ardiac sources of embolism (absence of carotid studies), and
technically inadequate studies. TEEs were systematically
reviewed for the presence of LASP, deﬁned as an incomplete
fusion in the cranial segment of the overlap between the septum
primum and the septum secundum in the standard bicaval view,
with no evidence of right-to-left shunting on agitated saline
injection at rest or during Valsalva maneuver. Maximal diameterin each patient. Fifty randomly chosen transesophageal echo-
cardiograms were read by all 3 investigators (S.A.W., J.H.P.,
and C.A.S.) independently for the presence or absence of septal
pouch, with 100% agreement among the 3 observers.
Logistic regression was used to identify clinical, demo-
graphic, and echocardiographic factors signiﬁcantly associated
with the presence of LASP and to examine the association of
LASP with cryptogenic stroke.
Of the initial 701 patients, 33 were excluded from analysis
because of technically inadequate TEE. Per the exclusion
criteria, 22 patients with atrial septal defects and 80 patients
with atrial-level shunts were also excluded. The ﬁnal analysis
was performed on the remaining 566 patients. Baseline char-
acteristics of the study population in terms of age, sex, race,
body mass, and comorbidities were essentially similar in subjects
with or without LASP, and the echocardiographic ﬁndings are
presented in Table 1. A total of 60 LASPs were identiﬁed in the
566 patients (prevalence 11%). The mean diameter of the
LASP os was 2.1  0.9 mm, and the mean depth of the LASP
was 11.1  5.4 mm. No signiﬁcant associations were noted
between the presence of LASP and any of the demographic,
clinical, and echocardiographic variables analyzed. A total of 66
patients were determined to have histories of cryptogenic stroke.
There was no association between LASP and cryptogenic stoke
(odds ratio: 1.3; 95% conﬁdence interval: 0.6 to 2.8; p ¼ 0.49).
Neither the depth (odds ratio: 0.9; 95% conﬁdence interval: 0.8
to 1.1; p ¼ 0.21) nor the diameter of the os (odds ratio: 0.9;
95% conﬁdence interval: 0.5 to 1.4; p ¼ 0.51) of the LASP had
any correlation with cryptogenic stroke.
The association of LASP with cryptogenic stroke remains
obscure (3). Our study does not support the notion that LASP
is associated with cryptogenic stroke. In the study by Tugcu
et al. (2), patients with LASP were younger and had lower
prevalence of hypertension compared with those without
LASPs. Per Tugcu et al. (2) a higher left atrial pressure (in
patients with hypertension) might force the septum primum
and septum secundum to fuse more completely, making LASP
less likely. However, we did not ﬁnd any correlation of hyper-
tension, diastolic dysfunction, or severity of mitral regurgitation
or mitral stenosis (all causes of elevated left atrial pressure) with
the prevalence of LASP.
Krishnan and Salazar (1), in their ﬁrst description of LASP,
showed the prevalence of LASP to be about 39%, while its
prevalence was 29% in the study by Tugcu et al. (2). The
prevalence of LASP of 11% in our study is signiﬁcantly lower
than in the aforementioned studies. The higher prevalence of
LASP seen by Krishnan and Salazar (1) may be explained by the
fact that it was an autopsy study, and imaging data were not
obtained. Similar to our study, Tugcu et al. (2) did use TEE for
the diagnosis of LASP, but their study population was exclu-
sively older than 50 years (mean age 70.6  9 years), with
histories of recent ischemic stroke. Whether the larger sample
size in our study (n ¼ 566) coupled with diverse indications for
TEE in our study sample (not exclusively post–ischemic stroke)
led to a lower prevalence of LASP in our study remains unknown.
Table 1. Associations of Echocardiographic Covariates With the Presence of LASP
Total
(n [ 566)
No LASP
(n [ 506)
LASP
(n [ 60)
Univariate Analysis
p Value*
Mean right ventricular systolic pressure, mm Hg 38 38 36 0.45
Left ventricular systolic function, % 0.95
Normal (>55%) 81 81 82
Mild dysfunction (45%–55%) 6 6 7
Moderate dysfunction (30%–45%) 7 7 7
Severe dysfunction (<30%) 3 3 2
Diastolic dysfunction, % 0.75
No diastolic dysfunction 75.00 75.00 68.00
Grade 1 20.00 19.00 28.50
Grade 2 1.00 1.50 0.00
Grade 3/4 4.00 4.50 3.50
Mean left atrial appendage emptying velocity, m/s 0.66 0.66 0.67 0.87
Right upper pulmonary vein
Mean os diameter, mm 14.98 14.83 16.38 0.18
Mean systolic velocity, m/s 0.77 0.80 0.36 0.18
Mean diastolic velocity, m/s 0.56 0.58 0.43 0.83
Right lower pulmonary vein
Mean os diameter, mm 11.07 11.01 11.73 0.47
Mean systolic velocity, m/s 0.69 0.72 0.36 0.84
Mean diastolic velocity, m/s 0.59 0.61 0.40 0.82
Left upper pulmonary vein
Mean os diameter, mm 14.28 14.23 14.83 0.55
Mean systolic velocity, m/s 0.97 1.02 0.41 0.28
Mean diastolic velocity, m/s 0.75 0.78 0.41 0.39
Left lower pulmonary vein
Mean os diameter, mm 12.77 12.90 11.54 0.20
Mean systolic velocity, m/s 0.71 0.70 0.33 0.29
Mean diastolic velocity, m/s 0.78 0.82 0.31 0.38
Mitral regurgitation, % 0.94
None/mild grade 83.80 83.80 83.30
Moderate/severe 16.20 16.20 16.70
Mitral stenosis, % 0.24
None/mild 97.20 97.40 95.00
Moderate/severe 2.80 2.60 5.00
*The p values refer to logistic regression analysis of the association of LASP with each of the variables examined.
LASP ¼ left atrial septal pouch.
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834In our opinion, although there are rare cases of clot inLASP, its role
in thrombogenicity and subsequent cardioembolic phenomena con-
tinues to be uncertain. Further studies are needed to analyze the
population-attributable risk for stroke due to LASP (3).
To conclude, our results show a lower overall prevalence of LASP
in this transesophageal echocardiographic study compared with
previous studies. No demographic, clinical, and echocardiographic
characteristics were found to be associated with the presence of
LASP. Finally, the presence of LASP was not found to be associ-
ated with increased risk for cryptogenic stroke.Siddharth A. Wayangankar, MD, MPH, Jigar H. Patel, MD,
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A “Stable” Coronary Plaque
Rupture Documented by
Repeated OCT Studies
A 78-year-old man with stable coronary artery disease and a
history of percutaneous coronary stenting in the mid segment of
the left anterior descending (LAD) artery for unstable angina wasFigure 1. Angiographic and OCT Findings at Baseline and 6 Months Later
Coronary angiography of the left anterior descending (LAD) coronary artery and frequen
assessment (A, B, C) and second assessment (D, E, F). (A) Angiography shows a de nov
segment (blue line). (B) FD-OCT cross-section shows the mid portion of the ruptured p
Arrowheads indicate side branches. (C) FD-OCT cross-section shows the distal portion o
(arrow). (D) Angiography shows severe intra-stent restenosis (red arrow) involving the
ruptured plaque 6 months after the ﬁrst assessment. The ruptured plaque maintains th
smooth ﬂoor and ruptured ﬁbrous cap (arrows). Arrowheads indicate side branches. (F
6 months later characterized by a smooth ﬂoor and thin ﬁbrous cap (arrow).admitted to San Giovanni Addolorata Hospital. Coronary angi-
ography and frequency domain-optical coherence tomography
(FD-OCT) revealed a new signiﬁcant stenosis distal to the
stented segment (Fig. 1A). FD-OCT identiﬁed a ruptured plaque
in the proximal LAD that was not associated with thrombus (1)
(Figs. 1B and 1C). Because the minimum lumen area at the
ruptured plaque site was large (7.75 mm2), the lesion was not
stented. The patient was discharged with double antiplatelet drugs
and a full dose of statin.
Six months later, the patient experienced exertional chest pain.
Coronary angiography and FD-OCT showed severe intra-stent
restenosis (Fig. 1D). The ruptured plaque in the proximal LAD,
observed in the previous study, was again imaged by FD-OCT and
showed the same morphologic features identiﬁed 6 months earlier
(rupture without thrombus) and unchanged minimum lumen area
(7.75 mm2) (Figs. 1E and 1F). To further investigate the features of
the ruptured plaque, an ofﬂine OCT tissue property software (2,3)
was applied, identifying a low OCT-derived macrophage density
of the ﬁbrous cap at both the ﬁrst OCT (Fig. 1G) and the second
OCT (6 months later) (Fig. 1H).
The presence of asymptomatic plaque rupture is a well-known
concept deriving from intravascular technique (4) and postmortemcy domain-optical coherence tomography (FD-OCT) of the ruptured plaque at the ﬁrst
o coronary stenosis (red arrow) located distally compared with the previous stented
laque (asterisk) characterized by a smooth ﬂoor and ruptured ﬁbrous cap (arrows).
f the ruptured plaque (asterisk) characterized by a smooth ﬂoor and thin ﬁbrous cap
overlapped stent segment. (E) FD-OCT cross-section shows the mid portion of the
e same morphological aspects. The ruptured plaque (asterisk) is characterized by a
) FD-OCT cross-section shows the distal portion of the ruptured plaque (asterisk)
